newsfilter
← Latest News
PR Newswire·

Ampio Pharmaceuticals Presents Corporate Overview at H.C. Wainwright Bioconnect Conference

ENGLEWOOD, Colo., Jan. 6, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE:AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced that it will present at